BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: He H, Dai J, Zhuo R, Zhao J, Wang H, Sun F, Zhu Y, Xu D. Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling. J Cell Physiol. 2018;233:9503-9515. [PMID: 29968912 DOI: 10.1002/jcp.26849] [Cited by in Crossref: 22] [Cited by in F6Publishing: 30] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Stankiewicz AM, Jaszczyk A, Goscik J, Juszczak GR. Stress and the brain transcriptome: Identifying commonalities and clusters in standardized data from published experiments. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2022. [DOI: 10.1016/j.pnpbp.2022.110558] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Bernal Astrain G, Nikolova M, Smith MJ. Functional diversity in the RAS subfamily of small GTPases. Biochem Soc Trans 2022:BST20211166. [PMID: 35356965 DOI: 10.1042/BST20211166] [Reference Citation Analysis]
3 Ramšak Ž, Modic V, Li RA, vom Berg C, Zupanic A. From Causal Networks to Adverse Outcome Pathways: A Developmental Neurotoxicity Case Study. Front Toxicol 2022;4:815754. [DOI: 10.3389/ftox.2022.815754] [Reference Citation Analysis]
4 Qin Y, Li G, Jin Y, Yao Q, Li R, Li X, Wang H. Long Non-Coding RNA maternally expressed 3 (MEG3) regulates isoflurane-induced cognitive dysfunction by targeting miR-7-5p. Toxicol Mech Methods 2022;:1-30. [PMID: 35164634 DOI: 10.1080/15376516.2022.2042881] [Reference Citation Analysis]
5 Jing X, Han J, Zhang J, Chen Y, Yuan J, Wang J, Neo S, Li S, Yu X, Wu J. Long non-coding RNA MEG3 promotes cisplatin-induced nephrotoxicity through regulating AKT/TSC/mTOR-mediated autophagy. Int J Biol Sci 2021;17:3968-80. [PMID: 34671212 DOI: 10.7150/ijbs.58910] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
6 Braga EA, Fridman MV, Filippova EA, Loginov VI, Pronina IV, Burdennyy AM, Karpukhin AV, Dmitriev AA, Morozov SG. LncRNAs in the Regulation of Genes and Signaling Pathways through miRNA-Mediated and Other Mechanisms in Clear Cell Renal Cell Carcinoma. Int J Mol Sci 2021;22:11193. [PMID: 34681854 DOI: 10.3390/ijms222011193] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
7 Chao X, Wang P, Ma X, Li Z, Xia Y, Guo Y, Ge L, Tian L, Zheng H, Du Y, Li J, Zuo Z, Xie L, Guo X. Comprehensive analysis of lncRNAs as biomarkers for diagnosis, prognosis, and treatment response in clear cell renal cell carcinoma. Mol Ther Oncolytics 2021;22:209-18. [PMID: 34514100 DOI: 10.1016/j.omto.2021.08.003] [Reference Citation Analysis]
8 Xu B, Qian Y, Hu C, Wang Y, Gao H, Yang J. Dexmedetomidine upregulates the expression of miR-493-5p, inhibiting growth and inducing the apoptosis of lung adenocarcinoma cells by targeting RASL11B. Biochem Cell Biol 2021;99:457-64. [PMID: 34296954 DOI: 10.1139/bcb-2020-0267] [Reference Citation Analysis]
9 Lyu X, Wang P, Qiao Q, Jiang Y. Genomic stratification based on microenvironment immune types and PD-L1 for tailoring therapeutic strategies in bladder cancer. BMC Cancer 2021;21:646. [PMID: 34059019 DOI: 10.1186/s12885-021-08350-1] [Reference Citation Analysis]
10 Li M, Yin B, Chen M, Peng J, Mu X, Deng Z, Xiao J, Li W, Fan J. Downregulation of the lncRNA ASB16-AS1 Decreases LARP1 Expression and Promotes Clear Cell Renal Cell Carcinoma Progression via miR-185-5p/miR-214-3p. Front Oncol 2020;10:617105. [PMID: 33680937 DOI: 10.3389/fonc.2020.617105] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
11 Shen H, Luo G, Chen Q. Long noncoding RNAs as tumorigenic factors and therapeutic targets for renal cell carcinoma. Cancer Cell Int 2021;21:110. [PMID: 33593347 DOI: 10.1186/s12935-021-01805-2] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
12 Gajda E, Grzanka M, Godlewska M, Gawel D. The Role of miRNA-7 in the Biology of Cancer and Modulation of Drug Resistance. Pharmaceuticals (Basel) 2021;14:149. [PMID: 33673265 DOI: 10.3390/ph14020149] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Li F, Jin Y, Pei X, Guo P, Dong K, Wang H, Chen Y, Guo P, Meng LB, Wang Z. Bioinformatics analysis and verification of gene targets for renal clear cell carcinoma. Comput Biol Chem 2021;92:107453. [PMID: 33636636 DOI: 10.1016/j.compbiolchem.2021.107453] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Ghafouri-Fard S, Shirvani-Farsani Z, Branicki W, Taheri M. MicroRNA Signature in Renal Cell Carcinoma. Front Oncol 2020;10:596359. [PMID: 33330087 DOI: 10.3389/fonc.2020.596359] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
15 Cheng G, Liu Y, Liu L, Ruan H, Cao Q, Song Z, Bao L, Xu T, Xiong Z, Liu J, Liu D, Liang H, Jiang G, Yang X, Yang H, Chen K, Zhang X. LINC00160 mediates sunitinib resistance in renal cell carcinoma via SAA1 that is implicated in STAT3 activation and compound transportation. Aging (Albany NY) 2020;12:17459-79. [PMID: 32921632 DOI: 10.18632/aging.103755] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Luo Y, Wang AT, Zhang QF, Liu RM, Xiao JH. RASL11B gene enhances hyaluronic acid-mediated chondrogenic differentiation in human amniotic mesenchymal stem cells via the activation of Sox9/ERK/smad signals. Exp Biol Med (Maywood) 2020;245:1708-21. [PMID: 32878463 DOI: 10.1177/1535370220944375] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
17 Han S, Zhang T, Kusumanchi P, Huda N, Jiang Y, Liangpunsakul S, Yang Z. Role of microRNA-7 in liver diseases: a comprehensive review of the mechanisms and therapeutic applications. J Investig Med 2020;68:1208-16. [PMID: 32843369 DOI: 10.1136/jim-2020-001420] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
18 Tu Y, Xie L, Chen L, Yuan Y, Qin B, Wang K, Zhu Q, Ji N, Zhu M, Guan H. Long non-coding RNA MEG3 promotes cataractogenesis by upregulating TP53INP1 expression in age-related cataract. Exp Eye Res 2020;199:108185. [PMID: 32841649 DOI: 10.1016/j.exer.2020.108185] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
19 Vigil-Garcia M, Demkes CJ, Eding JEC, Versteeg D, de Ruiter H, Perini I, Kooijman L, Gladka MM, Asselbergs FW, Vink A, Harakalova M, Bossu A, van Veen TAB, Boogerd CJ, van Rooij E. Gene expression profiling of hypertrophic cardiomyocytes identifies new players in pathological remodelling. Cardiovasc Res 2021;117:1532-45. [PMID: 32717063 DOI: 10.1093/cvr/cvaa233] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
20 Fukushima K, Satoh T, Kida H, Kumanogoh A. Revisiting Cell Death Responses in Fibrotic Lung Disease: Crosstalk between Structured and Non-Structured Cells. Diagnostics (Basel) 2020;10:E504. [PMID: 32708315 DOI: 10.3390/diagnostics10070504] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Yao X, Hu W, Zhang J, Huang C, Zhao H, Yao X. Application of cAMP-dependent catalytic subunit β (PRKACB) Low Expression in Predicting Worse Overall Survival: A Potential Therapeutic Target for Colorectal Carcinoma. J Cancer 2020;11:4841-50. [PMID: 32626531 DOI: 10.7150/jca.46156] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
22 Pan X, Cao YM, Liu JH, Ding J, Xie XY, Cao PG. MEG3 Induces Cervical Carcinoma Cells' Apoptosis Through Endoplasmic Reticulum Stress by miR-7-5p/STC1 Axis. Cancer Biother Radiopharm 2021;36:501-10. [PMID: 32379497 DOI: 10.1089/cbr.2019.3344] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
23 Fukushima K, Tsujino K, Futami S, Kida H. Natural Autoantibodies in Chronic Pulmonary Diseases. Int J Mol Sci 2020;21:E1138. [PMID: 32046322 DOI: 10.3390/ijms21031138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Barth DA, Slaby O, Klec C, Juracek J, Drula R, Calin GA, Pichler M. Current Concepts of Non-Coding RNAs in the Pathogenesis of Non-Clear Cell Renal Cell Carcinoma. Cancers (Basel) 2019;11:E1580. [PMID: 31627266 DOI: 10.3390/cancers11101580] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
25 Wang W, Xie Y, Chen F, Liu X, Zhong LL, Wang HQ, Li QC. LncRNA MEG3 acts a biomarker and regulates cell functions by targeting ADAR1 in colorectal cancer. World J Gastroenterol 2019; 25(29): 3972-3984 [PMID: 31413531 DOI: 10.3748/wjg.v25.i29.3972] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
26 Wang W, Xie Y, Chen F, Liu X, Zhong L, Wang H, Li Q. LncRNA MEG3 acts a biomarker and regulates cell functions by targeting ADAR1 in colorectal cancer. WJG 2019;25:0-0. [DOI: 10.3748/wjg.v25.i29.0000] [Reference Citation Analysis]
27 Li J, Jiang X, Li C, Liu Y, Kang P, Zhong X, Cui Y. LncRNA-MEG3 inhibits cell proliferation and invasion by modulating Bmi1/RNF2 in cholangiocarcinoma. J Cell Physiol 2019;234:22947-59. [PMID: 31119760 DOI: 10.1002/jcp.28856] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
28 Braga EA, Fridman MV, Loginov VI, Dmitriev AA, Morozov SG. Molecular Mechanisms in Clear Cell Renal Cell Carcinoma: Role of miRNAs and Hypermethylated miRNA Genes in Crucial Oncogenic Pathways and Processes. Front Genet 2019;10:320. [PMID: 31110513 DOI: 10.3389/fgene.2019.00320] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 10.7] [Reference Citation Analysis]
29 Luo Q, Cui M, Deng Q, Liu J. Comprehensive analysis of differentially expressed profiles and reconstruction of a competing endogenous RNA network in papillary renal cell carcinoma. Mol Med Rep 2019;19:4685-96. [PMID: 30957192 DOI: 10.3892/mmr.2019.10138] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
30 Al-Rugeebah A, Alanazi M, Parine NR. MEG3: an Oncogenic Long Non-coding RNA in Different Cancers. Pathol Oncol Res 2019;25:859-74. [PMID: 30793226 DOI: 10.1007/s12253-019-00614-3] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 14.0] [Reference Citation Analysis]